249 related articles for article (PubMed ID: 26670780)
21. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization.
Bhatt AB; Barnes TJ; Prestidge CA
Curr Drug Deliv; 2015; 12(1):47-55. PubMed ID: 25176029
[TBL] [Abstract][Full Text] [Related]
22. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
23. Preparation and Characterization of SN-38-Encapsulated Phytantriol Cubosomes Containing α-Monoglyceride Additives.
Ali MA; Noguchi S; Iwao Y; Oka T; Itai S
Chem Pharm Bull (Tokyo); 2016; 64(6):577-84. PubMed ID: 27250792
[TBL] [Abstract][Full Text] [Related]
24. A Combinatorial Statistical Design Approach to Optimize the Nanostructured Cubosomal Carrier System for Oral Delivery of Ubidecarenone for Management of Doxorubicin-Induced Cardiotoxicity: In Vitro-In Vivo Investigations.
Muheem A; Shakeel F; Warsi MH; Jain GK; Ahmad FJ
J Pharm Sci; 2017 Oct; 106(10):3050-3065. PubMed ID: 28552692
[TBL] [Abstract][Full Text] [Related]
25. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W
Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071
[TBL] [Abstract][Full Text] [Related]
26. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study.
Gabr MM; Mortada SM; Sallam MA
J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357
[TBL] [Abstract][Full Text] [Related]
27. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
Avachat AM; Parpani SS
Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
[TBL] [Abstract][Full Text] [Related]
28. Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies.
Faisal MM; Gomaa E; Ibrahim AE; El Deeb S; Al-Harrasi A; Ibrahim TM
AAPS PharmSciTech; 2024 May; 25(5):95. PubMed ID: 38710921
[TBL] [Abstract][Full Text] [Related]
29. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
Lee KW; Nguyen TH; Hanley T; Boyd BJ
Int J Pharm; 2009 Jan; 365(1-2):190-9. PubMed ID: 18790030
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
31. Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic(®) F127 cubosomes.
Akhlaghi SP; Ribeiro IR; Boyd BJ; Loh W
Colloids Surf B Biointerfaces; 2016 Sep; 145():845-853. PubMed ID: 27315333
[TBL] [Abstract][Full Text] [Related]
32. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M
J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194
[TBL] [Abstract][Full Text] [Related]
33. Incorporation of an Endogenous Neuromodulatory Lipid, Oleoylethanolamide, into Cubosomes: Nanostructural Characterization.
Younus M; Prentice RN; Clarkson AN; Boyd BJ; Rizwan SB
Langmuir; 2016 Sep; 32(35):8942-50. PubMed ID: 27524261
[TBL] [Abstract][Full Text] [Related]
34. Transfer of lipid and phase reorganisation in self-assembled liquid crystal nanostructured particles based on phytantriol.
Tilley A; Dong YD; Amenitsch H; Rappolt M; Boyd BJ
Phys Chem Chem Phys; 2011 Feb; 13(8):3026-32. PubMed ID: 21240427
[TBL] [Abstract][Full Text] [Related]
35. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
36. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
[TBL] [Abstract][Full Text] [Related]
37. Topical Delivery of Erythromycin Through Cubosomes for Acne.
Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
[TBL] [Abstract][Full Text] [Related]
38. Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin.
Nielsen LH; Rades T; Boyd B; Boisen A
Eur J Pharm Biopharm; 2017 Sep; 118():13-20. PubMed ID: 27993733
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.
Ahirrao M; Shrotriya S
Drug Dev Ind Pharm; 2017 Oct; 43(10):1686-1693. PubMed ID: 28574732
[TBL] [Abstract][Full Text] [Related]
40. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction.
Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T
Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]